Recovery of lymphocyte subsets and PHA responses after CBT
| Immune variable, median (range) . | Posttransplant time point . | |||
|---|---|---|---|---|
| 2 mo . | 4 mo . | 6 mo . | 1 y . | |
| ALC, cells/mm3 (NR: 500-5300) | 608 (85-7200) | 745 (145-2025) | 933 (173-6287) | 1554 (384-4774) |
| CD3+ T cells, cells/mm3 (NR: 822-1825) | 171 (7-3024) | 252 (8-1112) | 380 (38-1572) | 669 (148-3246) |
| CD4+ T cells, cells/mm3 (NR: 429-1131) | 120 (5-1584) | 203 (8-912) | 294 (30-1069) | 420 (22-891) |
| CD8+ T cells, cells/mm3 (NR: 209-768) | 22 (0-1440) | 25 (0-761) | 47 (0-909) | 204 (11-2574) |
| B cells, cells/mm3 (NR: 87-441) | 22 (0-3024) | 150 (0-1357) | 201 (0-3960) | 324 (0-1968) |
| NK cells, cells/mm3 (NR: 78-424) | 222 (41-1333) | 252 (29-717) | 221 (65-1519) | 220 (70-896) |
| PHA, CPM (NR: 109 576-256 486) | 66 816 (231-156 128) | 76 319 (667-162 912) | 86 944 (14 590-161 140) | 86 091 (6724-164 435) |
| Immune variable, median (range) . | Posttransplant time point . | |||
|---|---|---|---|---|
| 2 mo . | 4 mo . | 6 mo . | 1 y . | |
| ALC, cells/mm3 (NR: 500-5300) | 608 (85-7200) | 745 (145-2025) | 933 (173-6287) | 1554 (384-4774) |
| CD3+ T cells, cells/mm3 (NR: 822-1825) | 171 (7-3024) | 252 (8-1112) | 380 (38-1572) | 669 (148-3246) |
| CD4+ T cells, cells/mm3 (NR: 429-1131) | 120 (5-1584) | 203 (8-912) | 294 (30-1069) | 420 (22-891) |
| CD8+ T cells, cells/mm3 (NR: 209-768) | 22 (0-1440) | 25 (0-761) | 47 (0-909) | 204 (11-2574) |
| B cells, cells/mm3 (NR: 87-441) | 22 (0-3024) | 150 (0-1357) | 201 (0-3960) | 324 (0-1968) |
| NK cells, cells/mm3 (NR: 78-424) | 222 (41-1333) | 252 (29-717) | 221 (65-1519) | 220 (70-896) |
| PHA, CPM (NR: 109 576-256 486) | 66 816 (231-156 128) | 76 319 (667-162 912) | 86 944 (14 590-161 140) | 86 091 (6724-164 435) |
CPM, counts per minute; NR, normal range.